RW
ABBV icon

Rede Wealth’s AbbVie ABBV Stock Holding History

Rede Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$420K Buy
1,667
+5
+0.3% +$1.08K 0.14% 74
2026
Q1 		$362K Buy
1,662
+4
+0.2% +$887 0.13% 75
2025
Q4 		$379K Sell
1,658
-6,870
-81% -$1.56M 0.13% 68
2025
Q3 		$1.97M Buy
8,528
+6,781
+388% +$1.38M 1.55% 14
2025
Q2 		$324K Sell
1,747
-12
-0.7% -$2.23K 0.12% 82
2025
Q1 		$368K Sell
1,759
-130
-7% -$25.3K 0.13% 74
2024
Q4 		$336K Buy
1,889
+33
+2% +$6.07K 0.13% 77
2024
Q3 		$366K Sell
1,856
-21
-1% -$3.92K 0.14% 71
2024
Q2 		$322K Buy
1,877
+6
+0.3% +$994 0.3% 73
2024
Q1 		$341K Buy
1,871
+226
+14% +$38.9K 0.14% 68
2023
Q4 		$255K Buy
1,645
+5
+0.3% +$729 0.12% 77
2023
Q3 		$244K Sell
1,640
-820
-33% -$120K 0.12% 71
2023
Q2 		$331K Buy
2,460
+29
+1% +$4.25K 0.16% 71
2023
Q1 		$387K Buy
2,431
+24
+1% +$3.67K 0.2% 64
2022
Q4 		$389K Sell
2,407
-86
-3% -$13.2K 0.21% 56
2022
Q3 		$335K Sell
2,493
-10
-0.4% -$1.44K 0.2% 65
2022
Q2 		$383K Buy
2,503
+1
+0% +$153 0.22% 62
2022
Q1 		$405K Hold
2,502
– – 0.19% 65
2021
Q4 		$339K Sell
2,502
-508
-17% -$60K 0.17% 78
2021
Q3 		$324K Buy
3,010
+514
+21% +$58.7K 0.17% 84
2021
Q2 		$252K Buy
2,496
+201
+9% +$22.6K 0.13% 95
2021
Q1 		$249K Buy
2,295
+273
+14% +$29.2K 0.14% 91
2020
Q4 		$218K Buy
+2,022
New +$194K 0.15% 87

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rede Wealth's ABBV Position: Q2 2026 in Review

Rede Wealth increased its AbbVie (ABBV) stake by 0.3% in Q2 2026, buying an estimated $1.08K and bringing the position to 1,667 shares worth $420K. The position accounts for 0.14% of the portfolio, ranked #74.

Rede Wealth first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.97M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Rede Wealth held 1,667 shares of AbbVie worth $420K as of Q2 2026.
  • Rede Wealth bought 5 AbbVie shares in Q2 2026, an estimated $1.08K.
  • AbbVie made up 0.14% of Rede Wealth's portfolio in Q2 2026, its #74 holding.
  • Rede Wealth first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Rede Wealth's AbbVie position peaked at $1.97M in Q3 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Rede Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.